Myosana Therapeutics
Seattle, US · Founded 2018
Founders & leadership
ML
Matthew LumleyDirector
SC
Stanley C. FroehnerExecutive Officer, Director, Promoter
DM
Debra MillerDirector
NP
Nicholas P. WhiteheadExecutive Officer, Director, Promoter
Reported raises · per SEC filings
Form D private placements▶$6.4MraisedDec 2022 · 6 investors · OtherRule 506(b)
▶$6.4MraisedDec 2022 · 6 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Matthew LumleyDirector
- Stanley C. FroehnerExecutive Officer, Director, Promoter
- Debra MillerDirector
- Nicholas P. WhiteheadExecutive Officer, Director, Promoter
- Offering amount
- $6.4M
- Amount sold
- $6.4M
- First sale
- Nov 2022
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.